Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
This study has been completed.
Ministry of Science and Technology, India
First Posted: June 21, 2006
Last Update Posted: April 26, 2013
Information provided by (Responsible Party):
SK Sharma, All India Institute of Medical Sciences, New Delhi
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2012|
|Primary Completion Date:||October 2011 (Final data collection date for primary outcome measure)|